(PharmaNewsWire.Com, September 27, 2017 ) The North America Biopsy Devices Market was worth $527 million in 2016 and estimated to be growing at a CAGR of 6.82%, to reach $733 million by 2021. North America holds the biggest share in the global biopsy device market due to increasing geriatric population.
Biopsy device market is a market with huge potential. The key reason is the augmented need for the use of minimally invasive devices. There is an entire range of biopsy devices accessible in the market that can ease the process of cancer diagnosis.
The market drivers for the biopsy device are the augmented population awareness and increased cancer population, increased demand for screening tests and entry of emerging markets. Rising occurrence of several forms of cancer and a significant presence of unmet market demand for efficient and accurate cancer diagnostic procedures, especially in resource limited settings such as in emerging economies are expected to support future growth of the industry. The market limitations are mainly focused on equipment costs.
The North America biopsy devices market is segmented on the basis of product into instruments and consumables. Instruments segment is further segregated into manual, automated and semi-automated. Consumables segment is sub-segmented into reagents and kits. On the basis of type the market is bifurcated into needle biopsy and surgical biopsy. Needle biopsy segmented is further segmented into core needle biopsy, fine needle biopsy and vacuum-assisted biopsy. Surgical biopsy segment is divided among Incisional biopsy and Excisional biopsy. Based on application the market is segregated into scientific research, medical diagnosis, agricultural applications and genetic fingerprinting & sex determination. By End User, the market is divided into pharmaceutical and biology industry, academic research institute, contract research organizations and forensic labs.
Based on geography the market is analysed under various countries namely, USA and Canada. USA is leading the biopsy devices market followed by Canada.
The key companies dominating the biopsy devices market are Medtronic, Leica Biosystems, Hologic Inc., Boston Scientific Corporation, Becton, Cook Medical Inc., C.R. Bard Inc., Mauna Kea Technologies, Ethicon EndoSurgery Inc., Veran Medical Technologies, Dickinson and Company, Fujifilm Medical Systems, MDxHealth, Argon Medical Devices Inc and Intact Medical Corp.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
